ALBEMARLE CORP — Director's Dealing 2021

Nov 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ALBEMARLE CORP (ALB)
CIK: 0000915913
Period of Report: 2021-11-08

Reporting Person: Tozier Scott (EVP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-08	Common Stock	M	14010	$56.56	Acquired	69915	Direct
2021-11-08	Common Stock	M	22320	$56.08	Acquired	92235	Direct
2021-11-08	Common Stock	S	3098	$273.50	Disposed	89137	Direct
2021-11-08	Common Stock	S	4001	$274.39	Disposed	85136	Direct
2021-11-08	Common Stock	S	3090	$275.15	Disposed	82046	Direct
2021-11-08	Common Stock	S	5381	$276.42	Disposed	76665	Direct
2021-11-08	Common Stock	S	18960	$277.48	Disposed	57705	Direct
2021-11-08	Common Stock	S	1800	$278.05	Disposed	55905	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-08	Stock Option	$56.56	M	14010	Disposed	2026-02-26	Common Stock (14010.0)	Direct
2021-11-08	Stock Option	$56.08	M	22320	Disposed	2025-02-23	Common Stock (22320.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1631.80	Indirect

Footnotes

F1: Total number of shares of Common Stock held in the name of the Reporting Person under the Albemarle Corporation Retirement Savings Plan (the "Albemarle Savings Plan") as of the date of this Form 4.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $272.81 to $273.80, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $273.83 to $274.81, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.85 to $275.71, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $275.855 to $276.83, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.885 to $277.88, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $277.895 to $278.23, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: On February 26, 2016, the reporting person was granted stock options for 14,010 shares of Common Stock. The option fully vested on 02/26/2019.

F9: On February 24, 2015, the reporting person was granted stock options for 22,320 shares of Common Stock. The options vested in three equal installments over three years: 02/24/2018, 02/24/2019, and 02/24/2020.